
Fathom is on a mission to structure clinical data to bring efficiency and efficacy to healthcare systems around the world. We are the leader in autonomous medical coding, applying cutting-edge deep learning and NLP to code patient encounters with the highest automation rates and the broadest specialty coverage. Our AI technology delivers reduced costs, increased accuracy, and rapid turnaround times. We are backed by world-class investors including Lightspeed, Alkeon Capital, Google Ventures, 8VC, and Stanford as well as leading health systems and healthcare executives such as Cedars-Sinai and Jonathan Bush.

Fathom is on a mission to structure clinical data to bring efficiency and efficacy to healthcare systems around the world. We are the leader in autonomous medical coding, applying cutting-edge deep learning and NLP to code patient encounters with the highest automation rates and the broadest specialty coverage. Our AI technology delivers reduced costs, increased accuracy, and rapid turnaround times. We are backed by world-class investors including Lightspeed, Alkeon Capital, Google Ventures, 8VC, and Stanford as well as leading health systems and healthcare executives such as Cedars-Sinai and Jonathan Bush.
What they do: AI-powered medical coding automation platform and coding services
Headquarters: San Francisco, California, United States
Founders / CEO: Andrew Lockhart (co‑founder & CEO); Christopher Bockman (co‑founder)
Latest known funding: Series B ($46M announced Nov 9, 2022)
Employee count (snapshot): 71
Healthcare revenue cycle automation; medical coding and clinical documentation processing.
Healthtech / Medical coding automation
$46 million
Series B included participation from Cedars‑Sinai, Vituity's Inflect Health, ApolloMD, Founders Fund, and Tarsadia
“Backed by institutional and strategic investors including Alkeon Capital, Lightspeed Venture Partners, 8VC, Founders Fund, Tarsadia, Stanford, Cedars‑Sinai, and Inflect Health (Vituity)”
| Company |
|---|